Two dosages of a liquid suspension formulation of amoxicillin and potassium clavulanate were tested in 34 infants and children. The smaller dosage resulted in suboptimal plasma concentrations. With the greater dosage (3.3 mg of clavulanate per kg and 13.3 mg of amoxicillin per kg), the mean peak plasma concentrations were 1.6 ,ug clavulanic acid per ml and 4.9 jxg amoxicillin per ml.
mophilus influenzae strains which elaborate beta-lactamase and thus are resistant to ampicillin and related drugs. The-combination of clavulanic acid with amoxicillin (Augmentin, Beecham Pharmaceuticals) provides a novel approach to increasing the clinical utility of amoxicillin.
A liquid suspension of amoxicillin and potassium clavulanate in a 4:1 ratio by weight was tested in infants and children. The suspension contained 4 mg potassium clavulanate per ml and 16 mg amoxicillin per ml. Two dosages were tested; the smaller was approximately 1.7 mg of clavulanate per kg with 6.6 mg of amoxicillin per kg, and the larger was approximately 3.3 mg of clavulanate per kg and 13.3 mg of amoxicillin per kg. There were 17 children in each group. Each dose was substituted for one dose of the medication the child was receiving for treatment of otitis media or dermatological infections (12 h or more had elapsed since the previous dose of antibiotic).
Blood samples were collected immediately before the dose and at 20, 40, 60, 120, 180, and 240 min thereafter. Plasma was separated and stored at -70°C for no longer than 72 h before the assay was performed.
Clavulanic acid was assayed by a microdisk agar diffusion method by using an overnight seed culture of penicillinase-producing Klebsiella pneumoniae (ATCC 29665) grown in tryptose phosphate broth without dextrose. A sample of 1.5 ml of the seed culture was added per 100 ml of nutrient agar, and penicillin G-potassium was added at a concentration of 60 ,g/ml. The reference standard was clavulanic acid lithium (Beecham) in pooled normal human plasma.
Twenty-Ru amounts of standards and samples were added to 6.35-mm disks in triplicate. Amoxicillin trihydrate was incorporated into the standards at a 1:4 ratio of clavulanic acid to amoxicillin. The concentrations of clavulanic acid were doubling dilutions from 1.6 to 0.1 ,g/ ml.
Penicillinase in the seeded agar is inactivated by clavulanic acid diffusing from the disk, thereby causing a zone of inhibition due to penicillin activity against the assay organism.
Amoxicillin was assayed by a standard disk diffusion microbioassay with Sarcina lutea (ATCC 9341).
Mean plasma concentrations of clavulanic acid and amoxicillin are shown in Table 1 . Antimicrobial activity was not encountered in predose plasma specimens of 28 specimens assayed for clavulanic acid or in 15 specimens assayed for amoxicillin. In the remaining specimens, the amount of antimicrobial activity was less than 0.1 Rg/ml in all except one specimen with 1.7 pxg/ml activity in the amoxicillin assay; this effect could have been due to residual antibiotic or to other serum factors.
Peak plasma concentrations of each drug were found in most patients 60 min after the dose, with a range from 40 min to 2 h. The means of peak concentrations of clavulanic acid were 0.78 ,ug/ml and 1.53 ,ug/ml with the smaller and larger dosages, respectively. With amoxicillin, the means of peak values were 2.76 and 4.94 ,ug/ml. The mean ratios of peak values of amoxicillin to clavulanic acid were 3.5 and 3.1 with the smaller and larger dosages, respectively.
After the smaller dose the ratios of amoxicillin to clavulanic acid increased with time. With the larger dose they remained more constant, but mostly less than the 4:1 ratio of ingested drug. The mean ratios for all time periods were 4.6 Table 2 . The plasma half-life of clavulanic acid is slightly shorter than that of amoxicillin, and half-lives of both drugs are somewhat longer after the larger dose. This may be due to a more prolonged period of absorption of the larger volume of medication. Apparent volume of distribution of clavulanic acid is less than that of amoxicillin, and mean plasma clearance rates of amoxicillin are somewhat more rapid. In general, differences in pharmacokinetic features between the two drugs are small, and the drugs make a suitable pair from that standpoint.
The single dose of the amoxicillin and clavulanic acid combination was well tolerated by all of the children.
Reeves et al. (3) have reported that concentrations of 1 ,ug of clavulanic acid per ml consistently render beta-lactamase-producing strains of S.
aureus and H. influenzae susceptible to usual blood concentrations of amoxicillin, while Hunter et al. (2) have found that 2.5 ,ug/ml is required to achieve that effect. It appears that the lower dosage we tested produced suboptimal plasma concentrations of clavulanic acid. We propose that the larger dosage of 3.3 mg of clavulanic acid per ml be the minimum amount used for therapeutic trials with the combination. This study was supported by a grant from Beecham Laboratories.
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